E & P Valuation $24.40
We have increased our probability of success for NNZ-2591 in Phelan-McDermid syndrome and other indications in the pipeline (Pitt Hopkins, Angelman, Prader-Willi). The probability of success in Phase 2 for PMS has been increased to 100%, while for the other indications this probability has been increased by 5pp.
E & P Valuation $24.40We have increased our probability of...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.85 |
Change
0.510(2.39%) |
Mkt cap ! $2.801B | |||
| Open | High | Low | Value | Volume |
| $21.50 | $22.27 | $21.49 | $9.454M | 431.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 589 | $21.85 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.86 | 225 | 14 |
View Market Depth
| Last trade - 13.24pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$21.90 |
Change
0.510 ( 2.48 %) |
||||
| Open | High | Low | Volume | ||
| $21.56 | $22.26 | $21.50 | 107574 | ||
| Last updated 13.42pm 16/05/2024 ? | |||||
| NEU (ASX) Chart |